ArticleCancers2023

Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types.

Irina Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.